3 Asian Stocks Estimated To Be Up To 46.1% Below Intrinsic Value

As global markets navigate heightened uncertainty and mixed economic signals, Asian stocks present intriguing opportunities for value-seeking investors. In this environment, identifying undervalued stocks—those trading below their intrinsic value—can be a strategic approach to potentially capitalize on market inefficiencies.

Top 10 Undervalued Stocks Based On Cash Flows In Asia

Click here to see the full list of 277 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.

We'll examine a selection from our screener results.

BMC Medical (SZSE:301367)

Overview: BMC Medical Co., Ltd. is engaged in the research, development, manufacturing, and supply of respiratory health medical equipment and consumables in China, with a market cap of CN¥5.76 billion.

Operations: BMC Medical generates revenue from its Surgical & Medical Equipment segment, amounting to CN¥779.20 million.

Estimated Discount To Fair Value: 46.1%

BMC Medical is trading at CN¥72.08, significantly below its estimated fair value of CN¥133.77, indicating it is undervalued based on cash flows. Despite a forecasted low return on equity of 9.4% in three years, the company expects significant earnings growth at 31.32% annually and revenue growth of 22.5%, outpacing the Chinese market averages. However, profit margins have declined from last year’s 28.3% to 19.5%. Recent buyback activity completed shares worth CN¥42.25 million.

• Our growth report here indicates BMC Medical may be poised for an improving outlook.
• Take a closer look at BMC Medical's balance sheet health here in our report.

Auras Technology (TPEX:3324)

Overview: Auras Technology Co., Ltd. is involved in the manufacturing, processing, and retailing of electronic materials and computer cooling modules across various regions including China, Taiwan, Ireland, Singapore, the United States, and internationally with a market cap of NT$55.06 billion.

Operations: The company's revenue is primarily derived from its Electronic Components & Parts segment, which generated NT$15.78 billion.

Estimated Discount To Fair Value: 36.7%

Auras Technology, trading at NT$606, is significantly undervalued based on cash flows with an estimated fair value of NT$957.43. The company reported a strong earnings increase to NT$1.89 billion for 2024 from NT$1.23 billion in the previous year and forecasts annual earnings growth of 35.2%, outpacing Taiwan's market average. Despite recent share price volatility, revenue is expected to grow by 22% annually, supported by robust financial performance and analyst consensus on future price appreciation.

• The growth report we've compiled suggests that Auras Technology's future prospects could be on the up.
• Delve into the full analysis health report here for a deeper understanding of Auras Technology.

Chroma ATE (TWSE:2360)

Overview: Chroma ATE Inc. is engaged in the design, assembly, manufacturing, sales, repair, and maintenance of software/hardware for computers and peripherals as well as computerized automatic test systems and electronic test instruments across Taiwan, China, the United States, and internationally with a market cap of NT$133.03 billion.

Operations: The company's revenue segments include NT$33.42 billion from the Measuring Instruments Business and NT$1.45 billion from Automated Transport Engineering.

Estimated Discount To Fair Value: 32.5%

Chroma ATE, trading at NT$316, is undervalued with a fair value estimate of NT$468.42. Earnings grew to NT$5.26 billion for 2024 from NT$3.98 billion the previous year, and are forecast to grow by 20.1% annually, surpassing Taiwan's market growth rate. Despite a volatile share price recently and a dividend not fully covered by cash flows, analysts agree on potential price increases following its inclusion in the FTSE All-World Index.

• According our earnings growth report, there's an indication that Chroma ATE might be ready to expand.
• Dive into the specifics of Chroma ATE here with our thorough financial health report.

Taking Advantage

• Explore the 277 names from our Undervalued Asian Stocks Based On Cash Flows screener here.
• Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
• Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.

Contemplating Other Strategies?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com